輸入代號或公司名稱後按 Enter
VCEL

Vericel Corp

-0.86 (-2.14%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 生物製劑SIC 2836
39.35USD191K成交股數2.0B市值82.0本益比(近四季)6.6股價營收比+22.5%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收77.5M+47%68.4M-9%67.5M+17%63.2M+20%52.6M+3%75.4M+65%57.9M+26%52.7M+28%51.3M45.6M45.9M41.0M
營業成本21.1M19.2M17.9M16.6M16.3M16.9M16.3M16.1M15.9M15.0M16.0M14.5M
毛利56.4M+55%49.3M-16%49.6M+19%46.6M+27%36.3M+3%58.5M+91%41.7M+39%36.6M+38%35.4M30.6M29.9M26.5M
毛利率72.8%72.0%73.5%73.7%69.0%77.6%71.9%69.5%68.9%67.2%65.2%64.7%
研發費用7.5M8.1M6.3M6.7M7.3M4.9M6.1M7.4M6.4M5.7M5.3M5.2M
銷售管理費用48.5M49.2M39.8M41.9M41.8M35.1M38.0M35.3M34.4M30.0M30.6M29.5M
營業利益434K-103%−8.1M-144%3.5M-240%−2.0M-66%−12.8M+134%18.5M-465%−2.5M-59%−6.0M-26%−5.5M−5.1M−6.0M−8.2M
營業利益率0.6%-11.8%5.1%-3.2%-24.3%24.5%-4.3%-11.5%-10.7%-11.1%-13.0%-19.9%
稅後淨利2.2M-120%−6.3M-132%5.1M-663%−553K-88%−11.2M+191%19.8M-641%−901K-82%−4.7M-38%−3.9M−3.7M−5.0M−7.5M
淨利率2.8%-9.2%7.5%-0.9%-21.4%26.3%-1.6%-8.9%-7.5%-8.0%-10.9%-18.3%
稀釋 EPS0.04-117%-0.12-130%0.10-600%-0.01-90%-0.23+188%0.40-600%-0.02-82%-0.10-38%-0.08-0.08-0.11-0.16
稀釋股數52.3M50.8M51.9M50.4M49.9M51.7M49.1M48.7M48.1M47.6M47.6M47.4M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金125M109M100M80.5M73.5M74.5M53.7M50.3M62.9M60.5M43.0M61.8M
應收帳款75.7M72.4M60.4M64.3M52.9M61.4M48.5M48.0M49.9M39.7M38.3M38.4M
存貨18.4M18.4M18.2M16.8M17.1M17.4M15.8M14.9M13.6M12.6M13.9M15.4M
總資產503M486M453M436M425M433M390M377M357M318M311M265M
有息負債
總負債133M129M131M129M129M141M133M134M123M114M112M71.1M
股東權益370M356M322M307M295M292M257M243M234M204M199M194M
負債比26.4%26.6%29.0%29.6%30.4%32.5%34.1%35.5%34.4%35.8%36.0%26.8%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流16.4M6.6M-8%7.2M7.9M
資本支出1.3M14.2M14.0M1.4M
自由現金流15.1M−7.6M+12%−6.8M6.4M
折舊攤銷3.3M2.7M1.4M1.2M
買回庫藏股
現金股利
自由現金流率22.1%-14.5%-13.3%15.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

產品/服務2025 年度 · 240M
MACI Implants And Kits240M100.0%+21.4%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025276M+16.5%16.5M6.0%0.3224.7M
FY2024237M+20.1%10.4M4.4%0.20−5.8M
FY2023198M+20.7%−3.2M-1.6%-0.0715.3M
FY2022164M+6.9%−16.7M-10.2%-0.3510.1M
FY2021153M+25.5%−7.5M-4.9%-0.1621.1M
FY2020122M+3.5%2.9M2.3%0.0614.9M
FY2019118M+29.7%−9.7M-8.2%-0.22−9.8M
FY201890.9M−8.1M-9.0%-0.20−3.1M